hydromorphone has been researched along with heroin in 57 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 24 (42.11) | 18.7374 |
1990's | 2 (3.51) | 18.2507 |
2000's | 3 (5.26) | 29.6817 |
2010's | 19 (33.33) | 24.3611 |
2020's | 9 (15.79) | 2.80 |
Authors | Studies |
---|---|
Kestenbaum, RS; Resnick, RB; Schwartz, LK; Smith, A | 1 |
Gorodetzky, CW; McQuinn, RL; Yeh, SY | 1 |
Baskerville, JC; Brands, B; Gowdey, CW; Hirst, M | 2 |
Foley, KM; Houde, RW; Lapin, J; Portenoy, R; Rogers, A; Wallenstein, SL | 1 |
Bruera, E; MacDonald, NR; Macmillan, K; Selmser, P | 1 |
Sawynok, J | 1 |
Brenneis, C; Bruera, E; MacDonald, RN | 1 |
Foley, KM; Houde, RW; Inturrisi, CE; Moulin, DE; Nip, TJ; Reidenberg, B; Wallenstein, S; Weinberg, DS | 1 |
Doedens, DJ; Forney, RB; Sawyer, WR; Waterhouse, GA | 1 |
Eddy, NB; May, EL | 1 |
Bastos, ML; Jukofsky, D; Mulé, SJ | 1 |
Kreuzer, H; Spiller, P | 1 |
Dole, VP; Kreek, MJ; Nyswander, ME | 2 |
Brown, SS; Clarke, RS; Dundee, JW; Hamilton, RC; Loan, WB; Morrison, JD | 1 |
Röthig, J | 1 |
Baskerville, JC; Brands, B; Gowdey, CW; Herne, R; Hirst, M | 1 |
Lincoln, CA; McBride, DC; McCoy, CB; Rivers, JE | 1 |
Bree, MP; Mello, NK; Mendelson, JH | 1 |
Ritter, AJ; Watson, CR; Wodak, AD | 1 |
MEYERSTEIN, AN | 1 |
HAMBURGER, E | 1 |
LASAGNA, L | 1 |
SHEMANO, I; WENDEL, H | 1 |
Buechler, NL; Eisenach, JC; Kim, SA; Martin, TJ; Porreca, F | 1 |
Anis, A; Brissette, S; Guh, D; Lauzon, P; Marsh, DC; Oviedo-Joekes, E; Schechter, MT | 1 |
Anis, A; Brissette, S; Guh, D; Krausz, M; Marsh, DC; Nosyk, B; Oviedo-Joekes, E; Schechter, MT | 1 |
Fletcher, J | 1 |
Anis, AH; Brissette, S; Chettiar, J; Lock, K; Marchand, K; Marsh, DC; Oviedo-Joekes, E; Schechter, MT | 1 |
Anis, AH; Brissette, S; Guh, D; Lock, K; Marsh, DC; Oviedo-Joekes, E; Schechter, MT; Sordo, L | 1 |
Guh, D; Lock, K; MacDonald, S; Marchand, K; Oviedo-Joekes, E; Schechter, MT | 1 |
Anis, AH; Brissette, S; Guh, D; Harrison, S; Janmohamed, A; Krausz, M; Lock, K; MacDonald, S; Marchand, K; Marsh, DC; Oviedo-Joekes, E; Schechter, MT | 1 |
Baumgartner, MR; Bosshard, MM; Kraemer, T; Madry, MM | 1 |
Anis, AH; Brissette, S; Guh, D; Harrison, S; Janmohamed, A; Jutha, S; Krausz, M; MacDonald, S; Marchand, K; Marsh, DC; Oviedo-Joekes, E; Schechter, MT; Zhang, DZ | 1 |
Anis, AH; Brissette, S; Guh, D; Harrison, S; Krausz, M; Lock, K; MacDonald, S; Marchand, K; Marsh, DC; Oviedo-Joekes, E; Palis, H; Schechter, MT | 2 |
Bigelow, GE; Brands, B; Dunn, KE; Marsh, DC | 1 |
Anis, AH; Bansback, N; Brissette, S; Guh, D; Harrison, S; Janmohamed, A; Krausz, M; MacDonald, S; Marsh, DC; Oviedo-Joekes, E; Schechter, MT | 1 |
Barbic, S; Burghardt, J; Choi, F; Frank, A; Jang, K; Krausz, M; Nikoo, M; Schütz, C; Song, MJ; Tabi, K; Vogel, M; Zafari, Z | 1 |
Linas, BP | 1 |
Agüera, A; Campos-Mañas, MC; Ferrer, I; Sánchez Pérez, JA; Thurman, EM | 1 |
Alsherbini, KH; Jasne, AS; Kanter, D; Pandhi, A; Smith, MS; Vagal, A | 1 |
Anis, AH; Brissette, S; Guh, D; Harrison, S; Lock, K; MacDonald, S; Marchand, K; Marsh, DC; Oviedo-Joekes, E; Palis, H; Schechter, MT | 1 |
Fairbairn, N; Goyer, MÈ; Le Foll, B; MacDonald, S; Meador, K; Oviedo-Joekes, E; Perreault, M; Ross, J; Sutherland, C; Trew, M; Turnbull, J | 1 |
Barrett, FS; Bigelow, GE; Brands, B; Dunn, KE; Marsh, DC | 1 |
Foreman, J; Harrison, S; MacDonald, S; Marchand, K; Oviedo-Joekes, E; Schechter, MT | 1 |
Beaumont, S; Brissette, S; Guh, D; Harrison, S; MacDonald, S; Marchand, K; Marsh, DC; Oviedo-Joekes, E; Palis, H; Schechter, MT | 1 |
Bowles, J; Maghsoudi, N; Werb, D | 1 |
Boyd, J; Brohman, I; Fairbairn, N; Fowler, A; Kerr, T; Mayer, S; McNeil, R | 1 |
Brissette, S; Guh, D; Harrison, S; MacDonald, S; Marsh, DC; Oviedo-Joekes, E; Palis, H; Schechter, MT | 1 |
Haines, M; O'Byrne, P | 1 |
Fairbairn, N; Harris, MT; Nolan, S; Seliga, RK; Turnbull, J; Walley, AY; Weinstein, ZM | 1 |
Bozinoff, N; Le Foll, B; Rubin-Kahana, DS; Tardelli, VS | 1 |
Bansback, N; Byres, D; Dobischok, S; Harrison, S; MacDonald, S; Marchand, K; Matzinger, E; Metcalfe, R; Oviedo-Joekes, E; Palis, H; Schechter, M | 1 |
7 review(s) available for hydromorphone and heroin
Article | Year |
---|---|
The therapeutic use of heroin: a review of the pharmacological literature.
Topics: Analgesia; Animals; Brain; Codeine; Depression; Euphoria; Female; Half-Life; Heroin; Humans; Hydromorphone; Kinetics; Liver; Male; Morphine; Morphine Derivatives; Neoplasms; Pain; Sex Factors; Solubility; Terminal Care; Water | 1986 |
Continuous Sc infusion of narcotics for the treatment of cancer pain: an update.
Topics: Heroin; Humans; Hydromorphone; Infusion Pumps; Morphine; Narcotics; Neoplasms; Pain | 1987 |
[Analgesics. 32].
Topics: Alphaprodine; Analgesics; Azepines; Benzimidazoles; Bridged-Ring Compounds; Codeine; Cyclazocine; Dextromoramide; Dextropropoxyphene; Fentanyl; Heroin; Humans; Hydromorphone; Isonipecotic Acids; Levallorphan; Levorphanol; Lysergic Acid Diethylamide; Methadone; Morphinans; Morphine; Nalorphine; Naphthoquinones; Oxymorphone; Pentazocine; Phenazocine; Phenoperidine | 1969 |
DRUG ADDICTION: A REVIEW.
Topics: Adolescent; Amphetamine; Amphetamines; Barbiturates; Cannabis; Codeine; Heroin; Humans; Hydromorphone; Jurisprudence; Meperidine; Mescaline; Methadone; Morphine Dependence; Nalorphine; Narcotic Antagonists; Psychotherapy; Statistics as Topic; Substance-Related Disorders | 1964 |
THE CLINICAL EVALUATION OF MORPHINE AND ITS SUBSTITUTES AS ANALGESICS.
Topics: Analgesics; Analgesics, Non-Narcotic; Antipyretics; Biomedical Research; Codeine; Cyclazocine; Dextromoramide; Dextropropoxyphene; Heroin; Humans; Hydromorphone; Isonipecotic Acids; Meperidine; Methadone; Methotrimeprazine; Morphine; Nalorphine; Narcotic Antagonists; Oxymorphone; Pentazocine; Phenazocine; Substance-Related Disorders; Toxicology | 1964 |
Patterns of use and adverse events reported among persons who regularly inject buprenorphine: a systematic review.
Topics: Analgesics, Opioid; Buprenorphine; Heroin; Humans; Hydromorphone; Opiate Substitution Treatment; Opioid-Related Disorders | 2022 |
Measuring the preferences of injectable opioid agonist treatment (iOAT) clients: Development of a person-centered scale (best-worst scaling).
Topics: Analgesics, Opioid; Health Services; Heroin; Humans; Hydromorphone; Opioid-Related Disorders | 2023 |
14 trial(s) available for hydromorphone and heroin
Article | Year |
---|---|
Evaluation of propranolol in opiate dependence.
Topics: Adult; Clinical Trials as Topic; Heroin; Heroin Dependence; Humans; Hydromorphone; Male; Propranolol; Substance Withdrawal Syndrome; Substance-Related Disorders | 1976 |
Clinical analgesic assay of repeated and single doses of heroin and hydromorphone.
Topics: Affect; Analgesics; Female; Heroin; Humans; Hydromorphone; Hypnotics and Sedatives; Male; Neoplasms; Pain Measurement; Pain, Postoperative; Time Factors | 1990 |
Studies of drugs given before anaesthesia. XVII: The natural and semi-synthetic opiates.
Topics: Clinical Trials as Topic; Codeine; Female; Heroin; Humans; Hydromorphone; Morphine; Oxymorphone; Placebos; Preanesthetic Medication | 1969 |
Diacetylmorphine versus methadone for the treatment of opioid addiction.
Topics: Administration, Oral; Adult; Cocaine-Related Disorders; Double-Blind Method; Drug Overdose; Female; Heroin; Heroin Dependence; Humans; Hydromorphone; Illicit Drugs; Injections; Male; Methadone; Substance Abuse Detection; Substance Abuse, Intravenous | 2009 |
Double-blind injectable hydromorphone versus diacetylmorphine for the treatment of opioid dependence: a pilot study.
Topics: Adult; Double-Blind Method; Follow-Up Studies; Heroin; Heroin Dependence; Humans; Hydromorphone; Injections; Methadone; Narcotics; Opioid-Related Disorders; Pilot Projects; Severity of Illness Index; Time Factors | 2010 |
A chance to stop and breathe: participants' experiences in the North American Opiate Medication Initiative clinical trial.
Topics: Adult; Analgesics, Opioid; Dose-Response Relationship, Drug; Female; Heroin; Humans; Hydromorphone; Injections, Subcutaneous; Male; Methadone; North America; Opioid-Related Disorders; Outcome Assessment, Health Care; Research Design; Young Adult | 2014 |
Predictors of non-use of illicit heroin in opioid injection maintenance treatment of long-term heroin dependence.
Topics: Adult; Female; Follow-Up Studies; Heroin; Heroin Dependence; Humans; Hydromorphone; Injections; Male; Narcotics; Time; Treatment Outcome | 2015 |
The SALOME study: recruitment experiences in a clinical trial offering injectable diacetylmorphine and hydromorphone for opioid dependency.
Topics: Analgesics, Opioid; Double-Blind Method; Female; Heroin; Humans; Hydromorphone; Male; Opioid-Related Disorders; Patient Selection; Substance Abuse, Intravenous; Time Factors | 2015 |
Hydromorphone Compared With Diacetylmorphine for Long-term Opioid Dependence: A Randomized Clinical Trial.
Topics: Adult; British Columbia; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Heroin; Heroin Dependence; Humans; Hydromorphone; Illicit Drugs; Injections, Intravenous; Intention to Treat Analysis; Long-Term Care; Male; Middle Aged; Needle-Exchange Programs; Substance Abuse Detection | 2016 |
Safety profile of injectable hydromorphone and diacetylmorphine for long-term severe opioid use disorder.
Topics: Adult; Analgesics, Opioid; Canada; Double-Blind Method; Drug Overdose; Female; Heroin; Heroin Dependence; Humans; Hydromorphone; Injections; Male; Middle Aged; Naloxone; Opioid-Related Disorders; Self Administration; Severity of Illness Index; Time Factors | 2017 |
Men's and women's response to treatment and perceptions of outcomes in a randomized controlled trial of injectable opioid assisted treatment for severe opioid use disorder.
Topics: Administration, Intravenous; Adult; Analgesics, Opioid; Double-Blind Method; Female; Heroin; Humans; Hydromorphone; Male; Middle Aged; Opioid-Related Disorders; Patient Reported Outcome Measures; Sex Characteristics; Substance Abuse, Intravenous; Treatment Outcome | 2017 |
Characteristics and response to treatment among Indigenous people receiving injectable diacetylmorphine or hydromorphone in a randomised controlled trial for the treatment of long-term opioid dependence.
Topics: Adult; Canada; Double-Blind Method; Female; Heroin; Humans; Hydromorphone; Inuit; Male; Middle Aged; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Treatment Outcome | 2018 |
Characterizing the subjective, observer-rated, and physiological effects of hydromorphone relative to heroin in a human laboratory study.
Topics: Administration, Intravenous; Adult; Analgesics, Opioid; Behavior Observation Techniques; Blood Gas Analysis; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Emotions; Heroin; Humans; Hydromorphone; Injections, Subcutaneous; Male; Pupil | 2018 |
Treatment with injectable hydromorphone: Comparing retention in double blind and open label treatment periods.
Topics: Analgesics, Opioid; Canada; Double-Blind Method; Heroin; Humans; Hydromorphone; Injections; Opioid-Related Disorders; Patient Acceptance of Health Care; Retrospective Studies | 2019 |
36 other study(ies) available for hydromorphone and heroin
Article | Year |
---|---|
Identification of diacetylmorphine metabolites in humans.
Topics: Adult; Animals; Cats; Chromatography, Gas; Chromatography, Ion Exchange; Chromatography, Thin Layer; Dogs; Glucuronates; Heroin; Humans; Hydrolysis; Hydromorphone; Male; Mass Spectrometry; Morphine Derivatives | 1977 |
Dependence in rats after one injection of heroin-, LAAM- or hydromorphone-zinc tannate.
Topics: Animals; Behavior, Animal; Body Temperature; Body Weight; Heroin; Heroin Dependence; Humans; Hydromorphone; Methadone; Methadyl Acetate; Naloxone; Rats; Substance Withdrawal Syndrome; Substance-Related Disorders | 1979 |
Decreased local toxicity with subcutaneous diamorphine (heroin): a preliminary report.
Topics: Adult; Aged; Colonic Neoplasms; Female; Heroin; Humans; Hydromorphone; Injections, Subcutaneous; Male; Middle Aged; Morphine; Neoplasm Metastasis; Ovarian Neoplasms; Pain, Intractable; Prostatic Neoplasms; Uterine Cervical Neoplasms | 1990 |
Dilaudid-related deaths--District of Columbia, 1987.
Topics: Adult; Alcohol Drinking; Cocaine; District of Columbia; Female; Heroin; Humans; Hydromorphone; Illicit Drugs; Injections, Intravenous; Male; Middle Aged; Risk Factors; Space-Time Clustering | 1988 |
Leads from the MMWR. Dilaudid-related deaths--District of Columbia, 1987.
Topics: Adult; Alcohol Drinking; Cocaine; District of Columbia; Female; Heroin; Humans; Hydromorphone; Illicit Drugs; Injections, Intravenous; Male; Middle Aged; Risk Factors; Space-Time Clustering | 1988 |
Sublingual absorption of selected opioid analgesics.
Topics: Administration, Sublingual; Adult; Analgesics, Opioid; Analysis of Variance; Biological Availability; Buprenorphine; Fentanyl; Heroin; Humans; Hydromorphone; Levorphanol; Methadone; Morphine; Mouth; Naloxone; Oxycodone; Time Factors | 1988 |
Heroin, morphine, and hydromorphone determination in postmortem material by high performance liquid chromatography.
Topics: Body Fluids; Chromatography, High Pressure Liquid; Forensic Medicine; Heroin; Humans; Hydrogen-Ion Concentration; Hydromorphone; Morphine | 1988 |
The search for a better analgesic.
Topics: Analgesics; Animals; Chemical Phenomena; Chemistry; Codeine; Heroin; Humans; Hydromorphone; Levorphanol; Meperidine; Methadone; Morphinans; Morphine Dependence; Structure-Activity Relationship | 1973 |
Evaluation of immunoassay methods for detection, in urine, of drugs subject to abuse.
Topics: Amphetamine; Apomorphine; Barbiturates; Chromatography, Thin Layer; Cocaine; Codeine; Cross Reactions; Cyclazocine; Dextromethorphan; Dextropropoxyphene; Evaluation Studies as Topic; Hemagglutination Inhibition Tests; Heroin; Humans; Hydromorphone; Levorphanol; Methadone; Methods; Microchemistry; Morphine; Nalorphine; Radioimmunoassay; Spectrometry, Fluorescence; Substance-Related Disorders; Time Factors; Tritium | 1974 |
[Analgesia in myocardial infarct].
Topics: Analgesics; Diazepam; Heart; Hemodynamics; Heroin; Humans; Hydromorphone; Meperidine; Methadone; Morphine; Myocardial Infarction; Nitrogen Oxides; Pain; Pentazocine; Respiration | 1974 |
Narcotic blockade.
Topics: Drug Tolerance; Follow-Up Studies; Heroin; Humans; Hydromorphone; Injections, Intravenous; Methadone; Morphine; Rehabilitation; Substance Withdrawal Syndrome; Substance-Related Disorders | 1966 |
Narcotic blockade--a medical technique for stopping heroin use by addicts.
Topics: Euphoria; Heroin; Humans; Hydromorphone; Methadone; Morphine; Substance Withdrawal Syndrome; Substance-Related Disorders | 1966 |
Sparingly-soluble narcotic zinc tannates cause protracted analgesia in rats.
Topics: Analgesics, Opioid; Animals; Body Weight; Delayed-Action Preparations; Heroin; Hydrolyzable Tannins; Hydromorphone; Male; Pain; Rats; Solubility; Time Factors; Zinc | 1980 |
Zinc tannate salts of heroin, LAAM and hydromorphone attenuate opiate withdrawal syndrome.
Topics: Animals; Behavior, Animal; Body Temperature; Body Weight; Codeine; Delayed-Action Preparations; Heroin; Humans; Hydromorphone; Male; Methadone; Methadyl Acetate; Opioid-Related Disorders; Rats; Substance Withdrawal Syndrome; Zinc | 1980 |
Dilaudid use: trends and characteristics of users.
Topics: Adult; Analgesics, Opioid; Cross-Sectional Studies; Female; Florida; Heroin; Heroin Dependence; Humans; Hydromorphone; Injections, Intramuscular; Injections, Intravenous; Male; Opioid-Related Disorders; Social Class; Socioeconomic Factors; Substance-Related Disorders; Time Factors; White People | 1980 |
Comparison of buprenorphine and methadone effects on opiate self-administration in primates.
Topics: Animals; Buprenorphine; Depression, Chemical; Disease Models, Animal; Feeding Behavior; Heroin; Humans; Hydromorphone; Macaca mulatta; Macaca nemestrina; Methadone; Morphinans; Opioid-Related Disorders; Self Administration | 1983 |
Separating politics and scientific research on heroin prescription.
Topics: Analgesics, Opioid; Australia; Clinical Trials as Topic; Drug Prescriptions; Heroin; Heroin Dependence; Humans; Hydromorphone | 2002 |
BARBITURATE USE IN NARCOTIC ADDICTS.
Topics: Barbiturates; Codeine; Drug Tolerance; Ethchlorvynol; Glutethimide; Heroin; Hydromorphone; Hypnotics and Sedatives; Meperidine; Meprobamate; Methadone; Morphine Dependence; Narcotics; Opium; Pentobarbital; Seizures; Statistics as Topic; Substance-Related Disorders; Toxicology; Urea | 1964 |
A RAPID SCREENING TEST FOR POTENTIAL ADDICTION LIABILITY OF NEW ANALGESIC AGENTS.
Topics: Analgesics; Analgesics, Non-Narcotic; Antipyretics; Behavior, Addictive; Codeine; Dextropropoxyphene; Heroin; Hydromorphone; Meperidine; Methadone; Mice; Morphine; Phenazocine; Research; Substance-Related Disorders; Toxicology | 1964 |
Opioid self-administration in the nerve-injured rat: relevance of antiallodynic effects to drug consumption and effects of intrathecal analgesics.
Topics: Adenosine; Analgesics, Opioid; Animals; Clonidine; Dose-Response Relationship, Drug; Fentanyl; Heroin; Hydromorphone; Infusions, Intravenous; Injections, Spinal; Male; Methadone; Morphine; Neuralgia; Pain; Rats; Rats, Inbred F344; Self Administration | 2007 |
Canada in breach of ethical standards for clinical trials.
Topics: Canada; Clinical Trials as Topic; Heroin; Heroin Dependence; Humans; Hydromorphone; Narcotics; Therapeutic Human Experimentation | 2014 |
Hair analysis for opiates: hydromorphone and hydrocodone as indicators of heroin use.
Topics: Analgesics, Opioid; Chromatography, Liquid; Female; Hair; Heroin; Heroin Dependence; Humans; Hydrocodone; Hydromorphone; Male; Morphine; Morphine Derivatives; Opiate Alkaloids; Substance Abuse Detection; Tandem Mass Spectrometry | 2016 |
Cost-effectiveness of hydromorphone for severe opioid use disorder: findings from the SALOME randomized clinical trial.
Topics: British Columbia; Cost-Benefit Analysis; Crime; Double-Blind Method; Equivalence Trials as Topic; Health Services; Heroin; Hospitalization; Humans; Hydromorphone; Methadone; Mortality; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Severity of Illness Index | 2018 |
Employment and paid work among participants in a randomized controlled trial comparing diacetylmorphine and hydromorphone.
Topics: Adult; Double-Blind Method; Educational Status; Employment; Female; Heroin; Humans; Hydromorphone; Male; Opioid-Related Disorders; Randomized Controlled Trials as Topic; Treatment Outcome; Young Adult | 2018 |
Commentary on Bansback et al. (2018): Estimating the cost of stigma against injection.
Topics: Cost-Benefit Analysis; Heroin; Humans; Hydromorphone; Methadone; Opioid-Related Disorders | 2018 |
Identification of opioids in surface and wastewaters by LC/QTOF-MS using retrospective data analysis.
Topics: Analgesics, Opioid; Chromatography, Liquid; Codeine; Data Analysis; Environmental Monitoring; Fentanyl; Heroin; Hydrocodone; Hydromorphone; Minnesota; Morphine; Morphine Derivatives; Oxycodone; Retrospective Studies; Substance Abuse Detection; Tandem Mass Spectrometry; Tramadol; Wastewater; Water Pollutants, Chemical | 2019 |
Cerebellar Hippocampal and Basal Nuclei Transient Edema with Restricted diffusion (CHANTER) Syndrome.
Topics: Adult; Alcoholic Intoxication; Amphetamines; Basal Ganglia; Benzodiazepines; Brain Edema; Central Nervous System Stimulants; Cerebellar Cortex; Cerebellum; Cocaine; Coma; Female; Heroin; Hippocampus; Humans; Hydrocephalus; Hydromorphone; Magnetic Resonance Imaging; Male; Middle Aged; Opiate Alkaloids; Pain, Postoperative; Stupor; Substance-Related Disorders; Syndrome | 2019 |
Injectable opioid agonist treatment for opioid use disorder: a national clinical guideline.
Topics: Analgesics, Opioid; Canada; Heroin; Humans; Hydromorphone; Injections, Intramuscular; Injections, Intravenous; Injections, Subcutaneous; Opiate Substitution Treatment; Opioid-Related Disorders; Self Administration | 2019 |
Individual differences in human opioid abuse potential as observed in a human laboratory study.
Topics: Administration, Intravenous; Adult; Analgesics, Opioid; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Emotions; Female; Heroin; Humans; Hydromorphone; Individuality; Injections, Subcutaneous; Male; Middle Aged; Opioid-Related Disorders; Self Report | 2019 |
Building healthcare provider relationships for patient-centered care: A qualitative study of the experiences of people receiving injectable opioid agonist treatment.
Topics: Administration, Intravenous; Adult; Attitude of Health Personnel; Female; Grounded Theory; Health Personnel; Health Status; Heroin; Humans; Hydromorphone; Interviews as Topic; Male; Middle Aged; Narcotics; Opioid-Related Disorders; Patient-Centered Care; Professional-Patient Relations; Qualitative Research | 2020 |
Physician Communication in Injectable Opioid Agonist Treatment: Collecting Patient Ratings With the Communication Assessment Tool.
Topics: Analgesics, Opioid; Communication; Heroin; Humans; Hydromorphone; Physicians | 2020 |
Expanding access to diacetylmorphine and hydromorphone for people who use opioids in Canada.
Topics: Analgesics, Opioid; Canada; Health Services Accessibility; Heroin; Humans; Hydromorphone; Opiate Overdose | 2020 |
Motivations to initiate injectable hydromorphone and diacetylmorphine treatment: A qualitative study of patient experiences in Vancouver, Canada.
Topics: Canada; Heroin; Humans; Hydromorphone; Motivation; Patient Outcome Assessment | 2020 |
Longitudinal patterns of cocaine use among patients receiving injectable hydromorphone or diacetylmorphine for the treatment of opioid use disorder: A growth curve modeling approach.
Topics: Adult; Analgesics, Opioid; Cocaine; Cocaine-Related Disorders; Female; Heroin; Humans; Hydromorphone; Male; Middle Aged; Opioid-Related Disorders | 2021 |
Injectable opioid agonist treatment: An evolutionary concept analysis.
Topics: Administration, Intravenous; Analgesics, Opioid; Canada; Harm Reduction; Heroin; Humans; Hydromorphone; Opiate Overdose; Opiate Substitution Treatment; Opioid-Related Disorders | 2021 |
Outcomes of Ottawa, Canada's Managed Opioid Program (MOP) where supervised injectable hydromorphone was paired with assisted housing.
Topics: Adult; Alcoholism; Analgesics, Opioid; Canada; Female; Heroin; Housing; Humans; Hydromorphone; Opioid-Related Disorders; Retrospective Studies | 2021 |